Hot Features
プレミアム
MeiraGTx Holdings PLC (MGTX)
NASDAQ
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Dr. Alexandria ForbesCEO, President & Director | -62.00k | 568.54k | Automatic Disposition | 9.17 | 1.39M | -4.28% |
| 2026-01-07 | Dr. Robert K. ZeldinChief Medical Officer | -7.81k | 60.40k | Sale to Issuer | 7.73 | 146.20k | -5.07% |
| 2026-04-21 | Mr. Richard Brian GirouxCOO & CFO | -56.00k | 572.32k | Automatic Disposition | 10.22 | 1.06M | -5.01% |
| 2026-04-07 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -27.66k | 258.91k | Automatic Disposition | 9.36 | 668.51k | -3.97% |
| 2026-03-24 | Dr. Alexandria ForbesCEO, President & Director | -62.00k | 459.42k | Automatic Disposition | 7.41 | 1.45M | -4.10% |
| 2026-02-21 | Dr. Robert K. ZeldinChief Medical Officer | 4.55k | 0.00 | Derivative Exercise and Retained Stock | - | 172.89k | 2.70% |
| 2026-02-21 | Dr. Robert K. ZeldinChief Medical Officer | -2.95k | 21.99k | Derivative Exercise and Sale | 7.45 | 172.89k | - |
| 2026-02-21 | Mr. Robert J. WollinGeneral Counsel & Secretary | 5.30k | 0.00 | Derivative Exercise and Retained Stock | - | 57.38k | 10.18% |
| 2026-02-21 | Mr. Robert J. WollinGeneral Counsel & Secretary | -5.95k | 44.32k | Derivative Exercise and Sale | 7.45 | 57.38k | - |
| 2026-02-21 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | 13.25k | 0.00 | Derivative Exercise and Retained Stock | - | 696.17k | 1.94% |
| 2026-02-21 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -11.75k | 87.54k | Derivative Exercise and Sale | 7.45 | 696.17k | - |
| 2026-02-21 | Mr. Richard Brian GirouxCOO & CFO | 28.27k | 0.00 | Derivative Exercise and Retained Stock | - | 1.12M | 2.60% |
| 2026-02-21 | Mr. Richard Brian GirouxCOO & CFO | -31.73k | 236.36k | Derivative Exercise and Sale | 7.45 | 1.12M | - |
| 2026-02-21 | Dr. Alexandria ForbesCEO, President & Director | 29.45k | 0.00 | Derivative Exercise and Retained Stock | - | 1.51M | 1.99% |
| 2026-02-21 | Dr. Alexandria ForbesCEO, President & Director | -33.05k | 246.21k | Derivative Exercise and Sale | 7.45 | 1.51M | - |
| 2026-01-17 | Dr. Robert K. ZeldinChief Medical Officer | 21.05k | 0.00 | Derivative Exercise and Retained Stock | - | 168.34k | 14.29% |
| 2026-01-17 | Dr. Robert K. ZeldinChief Medical Officer | -13.95k | 103.52k | Derivative Exercise and Sale | 7.42 | 168.34k | - |
| 2026-01-17 | Mr. Robert J. WollinGeneral Counsel & Secretary | 22.79k | 0.00 | Derivative Exercise and Retained Stock | - | 52.08k | 77.84% |
| 2026-01-17 | Mr. Robert J. WollinGeneral Counsel & Secretary | -27.21k | 201.87k | Derivative Exercise and Sale | 7.42 | 52.08k | - |
| 2026-01-17 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | 39.75k | 0.00 | Derivative Exercise and Retained Stock | - | 682.92k | 6.18% |
| 2026-01-17 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -35.25k | 261.56k | Derivative Exercise and Sale | 7.42 | 682.92k | - |
| 2026-01-17 | Mr. Richard Brian GirouxCOO & CFO | 146.08k | 0.00 | Derivative Exercise and Retained Stock | - | 1.09M | 15.49% |
| 2026-01-17 | Mr. Richard Brian GirouxCOO & CFO | -163.92k | 1.22M | Derivative Exercise and Sale | 7.42 | 1.09M | - |
| 2026-01-17 | Dr. Alexandria ForbesCEO, President & Director | 146.08k | 0.00 | Derivative Exercise and Retained Stock | - | 1.48M | 10.93% |
| 2026-01-17 | Dr. Alexandria ForbesCEO, President & Director | -163.92k | 1.22M | Derivative Exercise and Sale | 7.42 | 1.48M | - |
| 2026-01-07 | Dr. Robert K. ZeldinChief Medical Officer | 17.50k | 0.00 | Derivative Exercise and Retained Stock | - | 146.20k | 13.60% |
| 2026-01-07 | Mr. Robert J. WollinGeneral Counsel & Secretary | 3.14k | 0.00 | Derivative Exercise and Retained Stock | - | 29.28k | 11.99% |
| 2026-01-07 | Mr. Robert J. WollinGeneral Counsel & Secretary | -4.36k | 33.73k | Derivative Exercise and Sale | 7.73 | 29.28k | - |
| 2026-01-07 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | 19.88k | 0.00 | Derivative Exercise and Retained Stock | - | 643.17k | 3.19% |
| 2026-01-07 | Dr. Stuart NaylorChief Scientific Officer of Ophthalmology | -17.63k | 136.24k | Derivative Exercise and Sale | 7.73 | 643.17k | - |
| 2026-01-07 | Mr. Richard Brian GirouxCOO & CFO | 23.68k | 0.00 | Derivative Exercise and Retained Stock | - | 943.32k | 2.57% |
| 2026-01-07 | Mr. Richard Brian GirouxCOO & CFO | -28.82k | 222.79k | Derivative Exercise and Sale | 7.73 | 943.32k | - |
| 2026-01-07 | Dr. Alexandria ForbesCEO, President & Director | 28.43k | 0.00 | Derivative Exercise and Retained Stock | - | 1.34M | 2.17% |
| 2026-01-07 | Dr. Alexandria ForbesCEO, President & Director | -34.07k | 263.39k | Derivative Exercise and Sale | 7.73 | 1.34M | - |
| 2025-12-31 | Perceptive Advisors LLC法人 | -2.30M | 18.19M | Sale to Issuer | 7.91 | 10.23M | -18.35% |
| 2025-12-23 | Dr. Alexandria ForbesCEO, President & Director | -6.25k | 0.00 | Other Disposition | - | 1.31M | -0.48% |
| 2025-11-20 | Mr. Robert J. WollinGeneral Counsel & Secretary | -5.00k | 0.00 | Other Disposition | - | 26.15k | -16.05% |
| 2025-10-21 | Mr. Richard Brian GirouxCOO & CFO | -24.00k | 212.88k | Automatic Disposition | 8.87 | 919.65k | -2.54% |
| 2025-10-07 | Dr. Alexandria ForbesCEO, President & Director | -47.50k | 398.53k | Automatic Disposition | 8.39 | 1.31M | -3.49% |
| 2025-07-22 | Mr. Richard Brian GirouxCOO & CFO | -24.00k | 204.48k | Automatic Disposition | 8.52 | 943.65k | -2.48% |
| 2025-07-08 | Dr. Alexandria ForbesCEO, President & Director | -47.50k | 378.58k | Automatic Disposition | 7.97 | 1.36M | -3.37% |
| 2025-06-30 | Mr. Richard Brian GirouxCOO & CFO | -5.00k | 0.00 | Other Disposition | - | 967.65k | -0.51% |
| 2025-06-06 | Dr. Keith Reginald HarrisIndependent Chairman of the Board | 75.00k | 0.00 | Derivative Exercise and Retained Stock | - | 125.00k | 150.00% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
